e& UAE’s Post

Today is World Cancer Day. Being the granddaughter of late Börje Larsson, professor of Physical and Radiation Biology and the inventor and mastermind behind the #gammaknife and the Positron emission tomography (PET) technique, I know that science matters and that great research progress has been made in the last decades when it comes to cancer treatment. But the fact is still that nearly one child a day is diagnosed with cancer in Sweden and is one of the leading causes of death among our children. But I’m not only the granddaughter of a man who devoted his life to science to make sure we find treatment for cancer, I’m also the wife of Peter who luckily survived deadly cancer thanks to science. Me and Peter have two wonderful daughters and our biggest wish is to see them grow up healthy and to see them have children of their own one day. Whatever we can do, big or small, to support and make tomorrow better today – let’s do it! I’m proud to work for Siemens Energy that has decided to give all profit from circular IT in Sweden to Swedish Childhood Cancer Fund (Barncancerfonden) to financially support the development of new treatment methods and continuing education in the field of childhood cancer. And can you imagine, last year Siemens Energy in Sweden’s circular IT activities in collaboration with Inrego generated 50.000 EUR to science! That's not peanuts. It is #sustainability in multiple dimensions. A big thanks to Christina Skoglund with team that make this happen and congratulations to the nomination to “Best sustainability action 2023 award” by Miljö & Utveckling !

MAKE SURE YOU GET A SEAT. Remember to sign up to the conference 'The green transition - a window of opportunities' taking place May 31st. SIGN UP HERE https://lnkd.in/dRESij52 How do we find our way to a sustainable competitive advantage and increase our competitive power? How do we make sure, that our huge investments in delivering on the green objectives will be capitalized into a sustainable topline growth? How do we address the market dynamics and increase the sustainability in the value chain at the same time? And how do we build innovation power and competences in the organization to deliver on the sustainable ambitions? Come and get INSPIRATION AND SOLUTIONS to the questions above. (Program in comments) The conference is at the same time af fundraising event for Kræftens Bekæmpelse (Danish Cancer Society) and their campaign 'Kræft er ikke for børn (Cancer is not for children). A big thanks to all the speakers, who participate pro bono. And Danish Industry who generously hosts the conference as well as Marlene Schou Knuthsen, MLDK Mærkevareleverandørerne, and Conference Manager for making the conference come alive. #sustainability #esg #greentransition #toplinegrowth #businessmodeldesign #SBTi #LCA #fmcg #foodinnovation

Glad to participate in these important and informative programs. For the @American Cancer Society (ACS) and our non-profit, non-partisan affiliate American Cancer Society Cancer Action Network (ACS CAN), health equity means everyone has a fair and just opportunity to prevent, find, treat, and survive cancer. It requires us to eliminate barriers and address needs to ensure everyone has the same opportunity to be healthy and cancer-free. See comments below for some great American Cancer Society tools that can help you and your teams work towards more equitable cancer care, wherever you are. #equityineducation #equitymatters #equityresearch

Missed the last virtual dialogue by Union for International Cancer Control (UICC)? A recording is available here: https://lnkd.in/dDhFxdqv Previous recordings can be found here: https://lnkd.in/dxyhAjVt #CancerControlAdvocate #CervicalCancerElimination

🗓️ On 20th February 2024, Dr Dhaval Trivedi, AI-PROGNOSIS project partner from King's College London, represented the AI-PROGNOSIS project at the 𝐂𝐑𝐈𝐒𝐏 - 𝐄𝐔𝐑𝐎𝐏𝐀𝐑 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐆𝐫𝐨𝐮𝐩 𝐌𝐞𝐞𝐭𝐢𝐧𝐠, along with valuable insights and updates on the project. 🌍𝐂𝐑𝐈𝐒𝐏 (𝐂𝐨𝐦𝐦𝐮𝐧𝐢𝐭𝐲 𝐟𝐨𝐫 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐈𝐧𝐯𝐨𝐥𝐯𝐞𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐒𝐮𝐩𝐩𝐨𝐫𝐭 𝐛𝐲 𝐏𝐰𝐏𝐬) is the EUROPAR expert patient group formed to promote public and patient involvement. The purpose of CRISP is to raise awareness of research, highlight the importance of participation of people (specifically with #Parkinson’s) in clinical research, and encourage patients and their carers to ask about clinical research when with their consultant. 𝐄𝐔𝐑𝐎𝐏𝐀𝐑 is a non-profit multi-disciplinary organisation of key opinion leaders across Europe dedicated to improving care for people with Parkinson’s and delivering excellence in clinical research. In order to empower people with #Parkinson’s and hear their voices in relation to research in line with INVOLVE, EUROPAR has led to the formation of CRISP. Read more about AI-PROGNOSIS: https://lnkd.in/eVUySYPZ #parkinsons #parkinsonsdisease #clinicalresearch #clinicalstudies #patientinvolvement

Ivana Domljanovic, a postdoc researcher at the University of Fribourg in Switzerland has discovered a blood test capable of detecting breast cancer. While traditional mammography identifies tissues that are already affected, this new and less invasive method will make possible to detect the body’s immune response to breast cancer, allowing early diagnosis and treatment. Learn more about this ground-breaking project in this video: https://lnkd.in/ePDZYHwa

The tides are slowly shifting, with more #capital being directed toward #healthspan. The cost of adding more weeks to end of life vs years gained by investing earlier in health make an easy business case, but humans are highly emotional creatures and we haven’t traditionally viewed these as objectively as logic might presume. Whether #investing capital or in oneself, the evidence is piling up that healthspan is a real market and an untapped opportunity for most individuals, with several winning propositions. Some key players are stepping forward with real capital to invest in opportunities with legitimate value. Einstein Institute for Aging Research is one of the top aging research communities, having long studied aging in the real world.

🙋♀️ 🙋♂️ Should this be you? We are looking for the next winner of The Hermit – our Health Tech Implementation Award. This award celebrates the #healthcare staff taking a chance and succeeding with implementing new, evidence-based technologies developed by pioneering #healthtech #startups - for the benefit of patients and staff. Meet one of last years’ three winners: 🔴 The Collaboration: Kræftværket, an app for young people with cancer. 🔴The Partners: Danske Regioner - Danish Regions (headed by Region Hovedstaden) adopted the solution Kræftværket provided by Daman 🔴The Need: Teenagers and young adults undergoing cancer treatment needed a solution to provide overview of their symptoms and activities, convenient access to medical information, and support through an online community with fellow cancer patients. Dr. med. Helle Pappot from Rigshospitalet initiated the app's development. Developed through a cross-regional collaboration with Daman, Kræftværket has been tested with the participation of patients and clinicians from all five Danish regions. 🚀 Kræftværket will undergo a national rollout in 2024, giving young people with cancer all across Denmark access to the app! Health tech is a necessity, and we need these partnerships for successful implementation at scale. This is why The Hermit returns for a third time in 2024. 🔎 Nominations are now open, until 31st January 2024 – the finalists will be invited to present on stage at Copenhagen Health Tech Summit 2024, where we announce the winning partnership! Read more and nominate: https://bit.ly/3GcurgM Andreas Dam | Line Rasmussen | Jesper Grønbæk | Jan Høegh | Anett Falussy | Martin Broch Pedersen | Giulia Galimberti | Mafalda Camara | Sean Aleksej Rehn | Oded Yair Menuhin | Jannik Topgaard Zeuthen | Nicolas Bouchet | Industriens Fond

⏰ Last Call❗Only one more day to explore cutting-edge innovations as start-ups from across Europe compete for a spot in the EIT Health Catapult Finals. Imagine a platform where Health Innovation meets investment, and that's what we've created with our latest showcase. The 29 semi-finalists, having honed their business models and pitching prowess through rigorous training with Catapult mentors, took the stage before a discerning jury. The competition is fierce, divided into two thrilling categories: Life Sciences and Healthtech!🔬 Get ready to binge-watch groundbreaking pitches that could shape the future of healthcare. Whether you're an investor looking for your next big venture, or an enthusiast keen on the latest in Life Sciences and Healthtech, this is where you need to be! 👉 Dive into this exclusive content and discover the next big thing in healthcare here: https://lnkd.in/eGiNDR5r #HealthcareInnovation #LifeSciences #HealthTech Verdify, Pan Cancer T, neuroClues

In 2023, AI dominated discussions across industries, especially in biotech. Insilico Medicine led, dosing the first patient with an AI-designed lung disease treatment in Phase 2 trials. Other standouts included Exscientia and Elucidata, pushing AI into drug development and data standardization. For more, visit here: https://bit.ly/442RIgz #AI #Data #DrugDevelopment #DiseaseTreatment